×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LRMR – larimar therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LRMR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/3
07:25 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at Citigroup Inc..
Medium
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at Citigroup Inc..
3/25
10:18 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $26.00 price target on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $26.00 price target on the stock.
3/25
08:17 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its price target raised by analysts at HC Wainwright from $15.00 to $16.00. They now have a "buy" rating on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its price target raised by analysts at HC Wainwright from $15.00 to $16.00. They now have a "buy" rating on the stock.
3/25
08:17 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its price target lowered by analysts at Robert W. Baird from $13.00 to $10.00. They now have an "outperform" rating on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its price target lowered by analysts at Robert W. Baird from $13.00 to $10.00. They now have an "outperform" rating on the stock.
3/24
07:00 am
lrmr
Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Medium
Report
Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results
3/3
04:05 pm
lrmr
Larimar Therapeutics to Present at the Leerink Partners Global Healthcare Conference
Medium
Report
Larimar Therapeutics to Present at the Leerink Partners Global Healthcare Conference
1/29
08:15 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $18.00 price target on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $18.00 price target on the stock.
1/24
08:02 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Medium
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/16
05:11 pm
lrmr
Form SCHEDULE 13G Larimar Therapeutics, Filed by: Opaleye Management Inc.
Medium
Report
Form SCHEDULE 13G Larimar Therapeutics, Filed by: Opaleye Management Inc.
4/11
07:46 am
lrmr
Form ARS Larimar Therapeutics, For: Dec 31
Low
Report
Form ARS Larimar Therapeutics, For: Dec 31
4/11
07:42 am
lrmr
Form DEF 14A Larimar Therapeutics, For: Apr 09
Low
Report
Form DEF 14A Larimar Therapeutics, For: Apr 09
3/24
04:52 pm
lrmr
Form 10-K Larimar Therapeutics, For: Dec 31
Low
Report
Form 10-K Larimar Therapeutics, For: Dec 31
3/24
07:04 am
lrmr
Form 8-K Larimar Therapeutics, For: Mar 24
High
Report
Form 8-K Larimar Therapeutics, For: Mar 24
2/4
03:46 pm
lrmr
Form SCHEDULE 13G Larimar Therapeutics, Filed by: BlackRock, Inc.
Low
Report
Form SCHEDULE 13G Larimar Therapeutics, Filed by: BlackRock, Inc.
1/27
04:11 pm
lrmr
Form 8-K Larimar Therapeutics, For: Jan 22
Low
Report
Form 8-K Larimar Therapeutics, For: Jan 22
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: